Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin
Nemet, D.; Kalenic, S.; Badanjak, A.; Bogdanic, V.; Davila, N.; Francetić, I.; Labar, B.
Bone Marrow Transplantation 4(Suppl): 105
1989
ISSN/ISBN: 0268-3369 PMID: 2697389 Document Number: 339437
Document emailed within 1 workday
Related Documents
De Jongh, C.A.; Joshi, J.H.; Newman, K.A.; Moody, M.R.; Wharton, R.; Standiford, H.C.; Schimpff, S.C. 1986: Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients American Journal of Medicine 80(5c): 96-100Andjelkovic, Z. 1980: Shock caused by gram-negative bacterial infection Srpski Arhiv Za Celokupno Lekarstvo 108(7-8): 777-789
Olofsson, P.; Olofsson, C.; Nylander, G.; Olsson, P. 1987: Endotoxin inactivation in plasma from patients with gram-negative infection--an in vitro study Progress in Clinical and Biological Research 231: 323-330
Márquez-Dávila, G.; Martínez-Barreda, C.; Suárez-Ramírez, I. 1991: Desiccated rattlesnake capsules: a potential source of gram-negative bacterial infection Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 43(4): 315-317
Esposito, S.; Galante, D.; Pennucci, C.; Barba, D.; Limauro, D.; Scioli, C. 1984: Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(3): 196-199
DiRienzo, A.Gregory.; van Der Horst, C.; Finkelstein, D.M.; Frame, P.; Bozzette, S.A.; Tashima, K.T. 2002: Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection Aids Research and Human Retroviruses 18(2): 89-94
Vázquez, L.; Encinas, M.P.; Morín, L.S.; Vilches, P.; Gutiérrez, N.; García-Sanz, R.; Caballero, D.; Hurlé, A.D. 1999: Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients Haematologica 84(3): 231-236
Chernobrovyĭ, N.P.; Kozak, I.A.; Besaraba, N.D.; Mishchenko, F.F.; Boĭchuk, A.P. 1988: Treatment of sepsis in patients with gram-negative infection Vrachebnoe Delo 1988(7): 107-109
Greenberg, R.N.; Wilson, K.M.; Kunz, A.Y.; Wedel, N.I.; Gorelick, K.J. 1991: Randomized, double-blind phase Ii study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infections Progress in Clinical and Biological Research 367: 179-186
Thamlikitkul, V.; Popum, S. 2016: Monitoring of Effectiveness and Safety of Colistin for Therapy in Resistant Gram-Negative Bacterial Infections in Hospitalized Patients at Siriraj Hospital Journal of the Medical Association of Thailand 99(3): 301-307
Sampi, K.; Hattori, M. 1992: Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1315-1320
Tan, T.J.; Tan, S.C. 2013: Concomitant early avascular necrosis of the femoral head and acute bacterial arthritis by enteric Gram-negative bacilli in four oncologic patients Singapore Medical Journal 54(5): E108-E112
Bastit, D.; Bonneau, J.C.; Rivat-Péran, L.; Ropartz, C.; Bercoff, E.; Pariente, E.A.; Senant, J.; Morcamp, D.; Bourreille, J.; Lemeland, J.E. 1984: Treatment of cirrhotic patients with specific immunoglobulins. Prevention of Gram-negative bacillary infections Presse Medicale 13(12): 744
Balotescu, C.; Israil, A.-M.; Lazăr, V.; Cernat, R.; Petrache, L.-M.; Dinu, C. 2002: Study of antibiotic influence on adherence capacity of gram positive and gram negative bacteria to the cellular substrate Bacteriologia Virusologia Parazitologia Epidemiologia 47(3-4): 131-135
Elsbach, P.; Weiss, J. 1995: Prospects for use of recombinant BPi in the treatment of gram-negative bacterial infections Infectious Agents and Disease 4(2): 102-109
Pignato, S.; Giammanco, G.M.; Giammanco, G. 1999: Molecular methods in the epidemiology of gram-negative bacterial infections Annali di Igiene: Medicina Preventiva e di Comunita 11(6): 423-429
Webb, G.; Robbins, M.J.; O'Hare, M.D.; Felmingham, D.; Ridgway, G.L.; Grüneberg, R.N. 1987: In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection International Journal of Clinical Pharmacology Research 7(3): 203-205
Tamayo y Orozco, J.A.; Ruiloba Benítez, J.; Ojeda, F. 1979: Infections caused by gram negative anaerobic bacteria and other associated bacterial strains Revista de Gastroenterologia de Mexico 44(3): 147-153
Kapasi, K.; Inman, R.D. 1992: HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells Journal of Immunology 148(11): 3554-3559
Klietmann, W.; Focht, J.; Nösner, K. 1987: Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 92-93